Belenos Biosciences, Inc. — Form D

Belenos Biosciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-17. The offering totals $55.0M, of which $48.0M was reported sold. Industry: Other.

Offering

• Filed: 2024-07-17
• Form: D
• Accession: 0002030450-24-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $55.0M
• Amount sold: $48.0M
• Remaining: $7.0M
• Investors: 2
• Date of first sale: 2024-07-08
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-519049

Issuer

• Name: Belenos Biosciences, Inc.
• CIK: 0002030450
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK, NY, 10022
• Phone: (212) 739-6400

Officers, directors & promoters (7)

More

• CIK 2030450 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search